MeSH D011628 - delayed puberty
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Padagis | Testosterone | Testosterone | 2017-02-28 | |||
| Testosterone | Testosterone Cypionate | 2005-01-31 | ||||
| Xiromed | Testosterone | Testosterone | 2020-04-16 | |||
| Testosterone | Testosterone Cypionate | 2023-04-13 | ||||
| Perrigo | Testosterone | Testosterone | 2013-01-31 | |||
| Cipla | Testosterone | Testosterone | 2018-01-29 | |||
| Testosterone | Testosterone Cypionate | 2018-06-19 | ||||
| Lupin Research | Testosterone | Testosterone | 2017-10-23 | |||
| Sandoz | Testosterone | Testosterone Cypionate | 2006-08-10 | |||
| Novartis | Methyltestosterone | Metandren | 1982-01-01 | |||
| Bausch Health Companies | Methyltestosterone | Android | 1982-01-01 | |||
| Methyltestosterone | Testred | 1982-01-01 | ||||
| Merck & Co | Methyltestosterone | Oreton | 1982-01-01 | |||
| Methyltestosterone | Oreton Methyl | 1982-01-01 | ||||
| Pfizer | Testosterone | Depo-testosterone | 1982-01-01 | |||
| Methyltestosterone | Methyltestosterone | 1982-01-01 |
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/2
Phase 2
100%1/1
Phase 3
67%2/3
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use